Favipiravir for the Treatment of Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

被引：0

作者：

Naveed, Aiman ^{[1
]}

Cheema, Huzaifa Ahmad ^{[1
]}

Shahid, Abia ^{[1
]}

Umer, Mohammad ^{[1
]}

ul Hussain, Hassan ^{[2
]}

Rehman, Mohammad Ebad Ur ^{[3
]}

Singh, Harpreet ^{[4
]}

Kurman, Jonathan S. ^{[4
]}

Sahra, Syeda ^{[5
]}

Ahmad, Faran ^{[6
,7
]}

Ahmad, Sharjeel ^{[8
]}

Iqbal, Sana ^{[9
]}

机构：

[1] King Edward Med Univ, Dept Med, Div Infect Dis, Lahore, Pakistan

[2] Dow Univ Hlth Sci, Dow Med Coll, Dept Med, Karachi, Pakistan

[3] Rawalpindi Med Univ, Dept Med, Rawalpindi, Pakistan

[4] Med Coll Wisconsin, Div Pulm & Crit Care, Milwaukee, WI USA

[5] Univ Oklahoma, Hlth Sci Ctr, Dept Infect Dis, Oklahoma City, OK USA

[6] Creighton Univ, Med Ctr, Infect Dis & Crit Care Med, Omaha, NE USA

[7] Vet Affairs Med Ctr, Crit Care Med, Omaha, NE USA

[8] Univ Illinois, Coll Med Peoria, Sect Infect Dis, Dept Internal Med, Peoria, IL USA

[9] Wayne State Univ, Dept Internal Med, Detroit, MI USA

来源：

AMERICAN JOURNAL OF THERAPEUTICS | 2024年 / 31卷 / 04期

关键词：

MULTICENTER; EFFICACY; SAFETY;

D O I：

10.1097/MJT.0000000000001688

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：e478 / e482

页数：5

共 50 条

[1] FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Naveed, Aiman
Cheema, Huzaifa
Shahid, Abia
Singh, Harpreet
Kurman, Jonathan
Rehman, Mohammad Ebad Ur
Umer, Mohammad
Sahra, Syeda
Ahmad, Faran
Ahmad, Sharjeel
[J]. CRITICAL CARE MEDICINE, 2024, 52
[2] Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Lan, Shao-Huan
Lai, Chih-Cheng
Chang, Shen-Peng
Lu, Li-Chin
Hung, Shun-Hsing
Lin, Wei-Ting
[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (06) : 759 - 766
[3] Statins in hospitalized COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
Ren, Yajuan
Wang, Guizuo
Han, Dong
[J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
[4] Efficacy and Safety of Favipiravir for the Treatment of COVID-19 Outpatients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Cheema, Huzaifa Ahmad
Ali, Abraish
Ali, Mirha
Shahid, Abia
Ghafoor, Muhammad Saqib
Ur Rehman, Mohammad Ebad
Sah, Ranjit
Sahra, Syeda
Ahmad, Sharjeel
[J]. AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (03) : e328 - e331
[5] The efficacy and safety of favipiravir in the treatment of nonsevere COVID-19: a systematic review and meta-analysis of randomized controlled trials
Bahar, M. A.
Kusuma, I. Y.
Matuz, M.
Ferenci, T.
Benko, R.
Csupor, D.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1491 - 1491
[6] Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials
Gupta, Samiksha
Padappayil, Rana Prathap
Bansal, Agam
Daouk, Salim
Brown, Brent
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 55 - 60
[7] Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
Toshie Manabe
Dan Kambayashi
Hiroyasu Akatsu
Koichiro Kudo
[J]. BMC Infectious Diseases, 21
[8] Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
Manabe, Toshie
Kambayashi, Dan
Akatsu, Hiroyasu
Kudo, Koichiro
[J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
[9] Hydroxychloroquine for treatment of COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
de Moraes, Vinicius Ynoe
Marra, Alexandre Rodrigues
Matos, Leandro Luongo
Serpa Neto, Ary
Rizzo, Luiz Vicente
Cendoroglo Neto, Miguel
Lenza, Mario
[J]. EINSTEIN-SAO PAULO, 2022, 20 : eRW0045
[10] Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
Al-Abdouh, Ahmad
Bizanti, Anas
Barbarawi, Mahmoud
Jabri, Ahmad
Kumar, Ashish
Fashanu, Oluwaseun E.
Khan, Safi U.
Zhao, Di
Antar, Annukka A. R.
Michos, Erin D.
[J]. CONTEMPORARY CLINICAL TRIALS, 2021, 101

← 1 2 3 4 5 →